ASSOCIATION BETWEEN ANOREXIA OF AGING AND DISABILITY IN OLDER COMMUNITY‐DWELLING MEXICANS
Odín Edgar Vázquez‐Valdez,S. Aguilar-Navarro,J. Ávila-Funes
DOI: https://doi.org/10.1111/j.1532-5415.2010.03095.x
2010-10-01
Journal of the American Geriatrics Society
Abstract:and renal functions (AST 38 U/L, ALT 62 U/L, creatinine 1.55 mg/dL). Methylprednisolone was tapered off over 4 days and replaced with oral prednisolone 30 mg/day, which was gradually tapered to 5 mg/day within 1 week. Unfortunately, the skin rash recurred along with worsening of liver and renal functions (AST 56 U/L, ALT 114 U/L, creatinine 1.82 mg/dL), and oral prednisolone was replaced with intravenous methylprednisolone 40 mg/day. The skin rash gradually resolved after 2 days, and methylprednisolone was again replaced with oral prednisolone 75 mg/day. In spite of the slow resolution, the skin rash disappeared completely 10 days later. Improvement and deterioration of liver and renal functions occurred in parallel with the resolution and recurrence of the skin rash. The patient was discharged and received oral prednisolone 75 mg/day subsequently. Unfortunately, Legionella pneumonia with cavitation developed 2 weeks later, although it was cured using antimicrobial therapy. Prednisolone was slowly tapered to 10 mg/day over 1 month. Allopurinol-induced DRESS syndrome, also called allopurinol hypersensitivity syndrome (AHS), is a severe adverse reaction characterized by skin rash, hematological abnormalities, and systemic involvement. The diagnostic criteria include the presence of at least two of three major criteria (worsening renal function, acute hepatocellular injury, and rash) or one major and one of three minor criteria (fever, leukocytosis, and eosinophilia). AHS was observed in approximately one in 260 patients who received allopurinol. The average interval between the initiation of allopurinol treatment and the onset of the syndrome is 2 to 6 weeks. Risk factors include old age, presence of the HLA-B 5801 allele, impaired renal function, concomitant use of diuretics, high dosage of allopurinol, alcoholism, and severe liver disease. High mortality has been reported in patients with sepsis, AST levels greater than 500 IU/L, and skin rash caused by toxic epidermal necrolysis. This is a case of a frail elderly man with multiple comorbidities and polypharmacy, all of which contributed to the difficulties and challenges in the diagnosis and management of the disease. Determination of the appropriate timing and manner of tapering of high-dose corticosteroids is difficult because rapid withdrawal may cause recurrence, such as that observed in this patient, who may require prolonged administration and slower tapering of drugs, although the cavitary legionellosis in this patient may also be related to corticosteroid-induced immunodeficiency. Fortunately, antimicrobial therapy cured the patient. Clinicians should be alert to the occurrence of DRESS syndrome in elderly patients with multiple comorbidities and polypharmacy who receive allopurinol. High dosage, long treatment duration, and slower tapering of steroids should be considered, and infections related to impaired immune function should be closely monitored in such patients.